Daxor Gross Margin 2010-2011 | DXR

Current and historical gross margin for Daxor (DXR) over the last 10 years. The current gross profit margin for Daxor as of December 31, 2011 is %.
Daxor Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2011-12-31 $0.00B 0 nan%
2011-09-30 $0.00B 0 nan%
2011-06-30 $0.00B 0 nan%
2011-03-31 $0.00B 0 nan%
2010-12-31 $0.00B 0 nan%
2010-09-30 $0.00B 0 nan%
2010-06-30 $0.00B 0 nan%
2010-03-31 $0.00B 0 nan%
2009-12-31 $0.00B 0 nan%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.639B 16.16
DaVita (DVA) United States $12.092B 15.02
Encompass Health (EHC) United States $8.769B 22.45
Chemed (CHE) United States $8.598B 26.65
Elanco Animal Health (ELAN) United States $8.421B 21.85
Option Care Health (OPCH) United States $5.225B 19.78
RadNet (RDNT) United States $4.303B 89.60
Amedisys (AMED) United States $3.120B 22.10
LifeStance Health (LFST) United States $2.863B 0.00
Astrana Health (ASTH) United States $2.307B 31.20
Addus HomeCare (ADUS) United States $1.815B 25.97
U.S Physical Therapy (USPH) United States $1.627B 43.54
Pennant (PNTG) United States $0.687B 36.29
Aveanna Healthcare Holdings (AVAH) United States $0.523B 0.00
Atai Life Sciences (ATAI) Germany $0.343B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00